Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vimu2g02335 | ATGCCTGCAAGCTTAAGGAATCTGTCACTTTCTCCCAAAATCTTCTCCTTCACCTTGCTTCTTTCATTAAACTCCCTTCTCTTTTTTCCATGTTGTTATTCCCTTGATCACCAAGGTGAGACTCTTATAGCATGGAAAAACAGTTTGAACATCACTTCCGATGTGTTACCATCATGGAACCCTTCAGCCTCAAACCCATGCAACTGGTTTGGGGTGTATTGCAACTCACAAGGAGAAGTTGTAGAGATAAACCTCAAGTCAGTCAACTTGCAAGGCTCATTGCCTTCAAATTTTCAACCTCTAAGGTCCTTGAAGTTTCTAATACTCTCATCAACCAACCTCACTGGAAGGATTCCAAAACAGATTGGAGACTATCTAGAGCTCACCTTTGTTGATCTCAGTGCCAATTCTCTCTTTGGTGAAATTCCAGAAGAAATTTGCAGCCTCAGAAAACTTACCAGTTTGTCTCTCCATACAAACTTCCTTGAAGGCAGCATTCCATCCAATATTGGCAATTTATCAAGCCTTGTGAACTTGACAATCTATGATAATCATCTCAGTGGTGAAATTCCAAAGAGCATTGGCTCTTTAAGCAAGCTCCAAGTTTTCAGAGCCGGTGGCAATAAGAACCTCAAGGGTGAGATCCCATGGGAGATTGGAAACTGCACCAACTTGGTCGTGCTAGGCCTTGCAGAAACCAGCATTTCTGGAAGTCTTCCTTCTTCAATCAAAATGCTGAAAAAAGTCAAAACCATAGCCATATACACAACTCTATTGTCAGGTTCTATTCCAGAAGAGATTGGCAATTGCAGTGAGTTGCATAACCTGTACTTACATCAGAACTCTATCTCTGGCTCAATACCAAGCCAAATTGGAGAACTTAACCAGCTTAAGAGTCTACTTTTGTGGCAAAACAATATAGTTGGTACCATCCCAGAAGAGCTTGGAAGCTGCACAGAGATCAAAGTCATAGACTTATCTGAAAACCTTCTCACTGGTAGCATACCAAGAAGTTTTGGCAACCTTTTAAATCTCCATGAGCTTCAGCTAAGTGTCAATCAGCTCTCTGGTATAATCCCTCCAGAGATTTCAAATTGCACTTCTCTGAATCAACTGGAACTTGACAACAATGCTCTCTCTGGTGAGATTCCTGATCTTATTGGAAACTTGAAAGGCTTGACTCTTTTCTTTGCATGGAAGAACAAGCTAACAGGAAACATTCCAGATAGTCTTTCTGAGTGCCAAGAACTTGAGGCAATTGATCTTTCGTACAACAACTTGATTGGTCCTGTACCCAGACAACTATTTGGGTTGAGGAACCTCACCAAACTTCTGCTTCTTTCCAATGAGTTATCAGGCTTTATACCACCTGATATAGGAAATTGCACAAGTCTCTACAGGCTGAGGTTGAATCACAACAGACTAGCAGGTAACATTCCTCCAGAGATTGGCAACTTGAAGAGTTTGAATTTTATGGACATGAGCAACAATCATCTCACTGGAGAGATTCCTCCAACACTATCTGGATGCCAGAATCTTGAGTTTCTAGACCTTCATTCCAACAGTCTCACTGGTTCTGTTCCAGATTCTCTTCCCAAAAGCCTTGAGTTGATTGACTTGTCAGATAACAGGCTAAGTGGTGCGTTGAGTCACACCATTGGTTCATTGGTTGAATTAACCAAACTCAACCTTGGAAAGAATCAGATAAGTGGAAGAATCCCAGCAGAGATCTTGTCCTGTACTAAGCTACAACTTCTGGACTTGGGAAGCAATAGCTTAGAAGGAGAAATTCCCAATGAAGTTGGTTTAATTCCTTCATTGGAAATCTCACTCAATCTTAGCTTCAATCAGTTTTCTGGTAAAATTCCATCCCAGTTCTCTGGTCTTACCAAACTAGGAGTGCTTGATCTGTCTCATAACAAGCTCTCAGGGAATTTAGATGCCCTCTCTGACCTTGAGAACCTTGTCTCCTTAAACGTGTCCTTCAATGGCTTCTCTGGTGAGTTACCTAACACTCGATTCTTCCACAAACTCCCTCTTAGTGATCTTGCTGAAAATCATGGTCTCTACATTGCCGGAGGTGTTGTAACTCCTGCTGACAAAGTCCATGCTTCATCGACCATGAAGTTCATCATGTCCATTCTCTTAAGCACCAGTGCAGTTCTAGTGCTGCTTACAATATATGTCTTGGTCCGTACTCACATTGCCAGCAAGGTTCTCATGGAAAATGAAGCTTGGGAGATGACTTTGTATCAGAAGCTTGATTTCTCCATTGATGACATTGTCTTCAATTTGACATCAGCCAATGTGATTGGCACTGGAAGCTCTGGAGTGGTGTACAAGGTGACAATTCCAAATGGTGAAACACTGGCAGTTAAAAAGATGTGGTCATCAGAAGAGTCAGGAGCATTCAATTCTGAAATTCAAACATTGGGGTCAATTAGGCACAAGAACATCATCAGGCTTCTGGGTTGGGGATCAAACAAGAACCTGAAGCTGCTGTTTTATGACTACCTCCCTAATGGAAGCCTGAGTTCATTGCTTCATGGTTCAGGAAAGGGAAAAGCTGAATGGGAGACAAGATATGATGTTATATTAGGTGTGGCACATGCACTAGCATATTTGCACCATGATTGTTTGCCTGCCATTATCCATGGAGATGTCAAAGCCATGAATGTGCTATTAGGTCCAGGATATCAACCTTACCTTGCTGACTTTGGCCTGGCAAGAATTGCAACTGAAATTGGTGACAATACTAACTCCAAGCCACTTCAAAGACATTACCTTGCTGGTTCTTATGGATACATGGCTCCTGAGCATGCATCTCTTCAGCCTATTACTGAAAAGAGTGATGTGTACAGTTTTGGCATGGTTCTACTTGAGGTTCTCAGTGGAAGGCACCCATTAGACCCAACTCTGCCAGGGGGTGCACACTTGGTTCAGTGGGTTAGGAACCACTTGGCTAGCAAAGGAGACCCTTCTGACATTCTTGACACAAAGTTGAGAGGGAGGGCTGACCCAACCATGCATGAAATGCTACAAACTCTAGCAGTGTCATTTCTATGTGTAAGCACTAGATCTGAAGAACGTCCAACAATGAAGGATATTGTTGCAATGCTGAAGGAAATTAGACCCCTTGAGACCTCAAGAACGGACTCTGATGTGTTGAAGGGAGGTTTAACTTCACACAGTTCTCCACCACCTCCTAAGAATGTGGTTTCACATGGATCTTCTACATGCTCTTATAATTTCTCAGATAACTCAATCAGTTGA | 3273 | 0.4229 | MPASLRNLSLSPKIFSFTLLLSLNSLLFFPCCYSLDHQGETLIAWKNSLNITSDVLPSWNPSASNPCNWFGVYCNSQGEVVEINLKSVNLQGSLPSNFQPLRSLKFLILSSTNLTGRIPKQIGDYLELTFVDLSANSLFGEIPEEICSLRKLTSLSLHTNFLEGSIPSNIGNLSSLVNLTIYDNHLSGEIPKSIGSLSKLQVFRAGGNKNLKGEIPWEIGNCTNLVVLGLAETSISGSLPSSIKMLKKVKTIAIYTTLLSGSIPEEIGNCSELHNLYLHQNSISGSIPSQIGELNQLKSLLLWQNNIVGTIPEELGSCTEIKVIDLSENLLTGSIPRSFGNLLNLHELQLSVNQLSGIIPPEISNCTSLNQLELDNNALSGEIPDLIGNLKGLTLFFAWKNKLTGNIPDSLSECQELEAIDLSYNNLIGPVPRQLFGLRNLTKLLLLSNELSGFIPPDIGNCTSLYRLRLNHNRLAGNIPPEIGNLKSLNFMDMSNNHLTGEIPPTLSGCQNLEFLDLHSNSLTGSVPDSLPKSLELIDLSDNRLSGALSHTIGSLVELTKLNLGKNQISGRIPAEILSCTKLQLLDLGSNSLEGEIPNEVGLIPSLEISLNLSFNQFSGKIPSQFSGLTKLGVLDLSHNKLSGNLDALSDLENLVSLNVSFNGFSGELPNTRFFHKLPLSDLAENHGLYIAGGVVTPADKVHASSTMKFIMSILLSTSAVLVLLTIYVLVRTHIASKVLMENEAWEMTLYQKLDFSIDDIVFNLTSANVIGTGSSGVVYKVTIPNGETLAVKKMWSSEESGAFNSEIQTLGSIRHKNIIRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGSGKGKAEWETRYDVILGVAHALAYLHHDCLPAIIHGDVKAMNVLLGPGYQPYLADFGLARIATEIGDNTNSKPLQRHYLAGSYGYMAPEHASLQPITEKSDVYSFGMVLLEVLSGRHPLDPTLPGGAHLVQWVRNHLASKGDPSDILDTKLRGRADPTMHEMLQTLAVSFLCVSTRSEERPTMKDIVAMLKEIRPLETSRTDSDVLKGGLTSHSSPPPPKNVVSHGSSTCSYNFSDNSIS | 1090 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vimu2g02335 | 1090 | SUPERFAMILY | RNI-like | 82 | 380 | - | - | |
Vimu2g02335 | 1090 | Gene3D | Ribonuclease Inhibitor | 273 | 433 | IPR032675 | - | |
Vimu2g02335 | 1090 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 610 | 695 | - | - | |
Vimu2g02335 | 1090 | PANTHER | LEUCINE-RICH REPEAT RECEPTOR PROTEIN KINASE EMS1 | 484 | 1044 | - | - | |
Vimu2g02335 | 1090 | Gene3D | Ribonuclease Inhibitor | 434 | 531 | IPR032675 | - | |
Vimu2g02335 | 1090 | Gene3D | Ribonuclease Inhibitor | 610 | 693 | IPR032675 | - | |
Vimu2g02335 | 1090 | Gene3D | Ribonuclease Inhibitor | 35 | 194 | IPR032675 | - | |
Vimu2g02335 | 1090 | FunFam | Probable LRR receptor-like serine/threonine-protein kinase At1g34110 | 194 | 285 | - | - | |
Vimu2g02335 | 1090 | ProSiteProfiles | Leucine-rich repeat profile. | 631 | 653 | IPR001611 | GO:0005515 | |
Vimu2g02335 | 1090 | SUPERFAMILY | Protein kinase-like (PK-like) | 763 | 1040 | IPR011009 | - | |
Vimu2g02335 | 1090 | Gene3D | Ribonuclease Inhibitor | 207 | 272 | IPR032675 | - | |
Vimu2g02335 | 1090 | MobiDBLite | consensus disorder prediction | 1054 | 1078 | - | - | |
Vimu2g02335 | 1090 | Gene3D | Transferase(Phosphotransferase) domain 1 | 839 | 1058 | - | - | |
Vimu2g02335 | 1090 | FunFam | LRR receptor-like serine/threonine-protein kinase RCH1 | 839 | 1057 | - | - | |
Vimu2g02335 | 1090 | SMART | serkin_6 | 765 | 1021 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vimu2g02335 | 1090 | Pfam | Protein kinase domain | 768 | 1037 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vimu2g02335 | 1090 | FunFam | Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 | 734 | 838 | - | - | |
Vimu2g02335 | 1090 | Pfam | Leucine rich repeat | 464 | 523 | IPR001611 | GO:0005515 | |
Vimu2g02335 | 1090 | Pfam | Leucine rich repeat | 321 | 379 | IPR001611 | GO:0005515 | |
Vimu2g02335 | 1090 | Pfam | Leucine rich repeat | 610 | 664 | IPR001611 | GO:0005515 | |
Vimu2g02335 | 1090 | FunFam | Leucine-rich receptor-like protein kinase family protein | 337 | 609 | - | - | |
Vimu2g02335 | 1090 | Gene3D | Ribonuclease Inhibitor | 532 | 609 | IPR032675 | - | |
Vimu2g02335 | 1090 | ProSiteProfiles | Protein kinase domain profile. | 765 | 1047 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vimu2g02335 | 1090 | ProSitePatterns | Protein kinases ATP-binding region signature. | 771 | 794 | IPR017441 | GO:0005524 | |
Vimu2g02335 | 1090 | SMART | LRR_typ_2 | 149 | 173 | IPR003591 | - | |
Vimu2g02335 | 1090 | SMART | LRR_typ_2 | 556 | 580 | IPR003591 | - | |
Vimu2g02335 | 1090 | SMART | LRR_typ_2 | 294 | 318 | IPR003591 | - | |
Vimu2g02335 | 1090 | SMART | LRR_typ_2 | 101 | 125 | IPR003591 | - | |
Vimu2g02335 | 1090 | SMART | LRR_typ_2 | 342 | 366 | IPR003591 | - | |
Vimu2g02335 | 1090 | SMART | LRR_typ_2 | 486 | 510 | IPR003591 | - | |
Vimu2g02335 | 1090 | SMART | LRR_typ_2 | 629 | 652 | IPR003591 | - | |
Vimu2g02335 | 1090 | SMART | LRR_typ_2 | 438 | 462 | IPR003591 | - | |
Vimu2g02335 | 1090 | SUPERFAMILY | L domain-like | 610 | 687 | - | - | |
Vimu2g02335 | 1090 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 883 | 895 | IPR008271 | GO:0004672|GO:0006468 | |
Vimu2g02335 | 1090 | FunFam | Leucine-rich receptor-like protein kinase family protein | 35 | 193 | - | - | |
Vimu2g02335 | 1090 | Pfam | Leucine rich repeat N-terminal domain | 36 | 75 | IPR013210 | - | |
Vimu2g02335 | 1090 | SUPERFAMILY | RNI-like | 292 | 607 | - | - | |
Vimu2g02335 | 1090 | PRINTS | Leucine-rich repeat signature | 535 | 548 | - | - | |
Vimu2g02335 | 1090 | PRINTS | Leucine-rich repeat signature | 629 | 642 | - | - | |
Vimu2g02335 | 1090 | MobiDBLite | consensus disorder prediction | 1048 | 1078 | - | - | |
Vimu2g02335 | 1090 | Gene3D | Phosphorylase Kinase; domain 1 | 731 | 838 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vimu2g02335 | Vimu-Chr2 | 18789430 | 18793038 | Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vimu2g02335 | 32 | 1089 | Receptor kinase-like Gene Family | AT5G56040 | 67.540 | 0.0 | 1430 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XI-1 | Vimu2g02335 | Pkinase | 1.8e-36 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vimu2g02335 | - | - | gmx:100802880 | 1971.82 |